Robin A. Nadar

Robin A. Nadar's research interest includes the development of novel drug delivery systems and theranostic agents in the treatment of cancer. He received his M.Sc. degree in Molecular Bioengineering at the Technical University of Dresden, Germany (2014). He further pursued a Ph.D. in the Regenerative Biomaterials group, Radboudumc (2015). His research focused on the treatment of bone metastases using bone-seeking & radioactive platinum-based anticancer drugs. He is currently a postdoc at the Applied Radiation and Isotopes group (2019). As Bioengineer, he is presently working on the RaCHy project funded by EURAMET in the framework of the EMPIR Health program. Currently, his research aims to determine the efficiency of combination therapies (radiotherapy and hyperthermia) both in vitro and in vivo by application of nanoparticles.

Robin A. Nadar

Postdoctoral Researcher